|Bid||10.95 x 0|
|Ask||11.10 x 0|
|Day's Range||10.77 - 11.20|
|52 Week Range||4.55 - 24.75|
|PE Ratio (TTM)||52.63|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Marijuana stocks are down to start 2018, as the expected date for the drug to become legal has suffered a delay. Find out what it means for stocks like Canopy Growth Corp. (TSX:WEED) and two others.
Aurora Cannabis Inc. (TSX:ACB) beefs up its capacity with Aurora Sun. Could the stock be heading for another parabolic surge?
Aphria Inc. (TSX:APH) stock continues to price in very optimistic expectations, while its earnings results are not so impressive.
Shares of licensed medical marijuana producer Aphria Inc. surged Monday on better than expected quarterly results and after news of a changing political tone on cannabis south of the border. Aphria reported a $12.9-million profit in its fiscal third quarter, boosted by the sale of some of its shares in U.S. company Liberty Health Sciences, and reduced production costs per gram of cannabis. The Leamington, Ont.-based producer's stock rose as much as 8.95 per cent the Toronto Stock Exchange on Monday, before closing at $12.24, up 7.37 per cent.
Cannabis Growth Corp. (TSX:WEED), Aurora Cannabis Inc. (TSX:ACB), and Aphria Inc. (TSX:APH) are all trading significantly lower than their highs, but fundamentals and valuations still do not support buying at this time.
Aphria Inc. (TSX:APH) has been struggling mightily this year, and it needs a good earnings report to pull itself out from the abyss.
While Canadian pot stocks beat the market by a wide margin last year, they are underperforming year-to-date. Aphria Inc. (TSX:APH) has been particularly hit.
Aurora Cannabis Inc. (TSX:ACB), Canopy Growth Corp. (TSX:WEED), and other pot stocks could be in for a disastrous end to 2018. Here's why investors should cash out on cannabis stocks while they still can.
Aphria Inc. (TSX:APH) is down big to start the year, but you shouldn't expect it to stay that way for much longer.
Top growth stocks like Dollarama Inc. (TSX:DOL) have been battered along with the broader Canadian stock market to start 2018.
Cannabis stocks are undergoing a correction. Will valuation rebounds for Aurora Cannabis Inc. (TSX:ACB) and other players outperform the TSX?
Canopy Growth Corp. (TSX:WEED) and Aphria Inc. (TSX:APH) are selling off. Is this a buy-the-dip opportunity before the next leg up? Or could the entire industry be a bubble on the verge of popping?
Canopy Growth Corp. (TSX:WEED), Aurora Cannabis Inc. (TSX:ACB) and Aphria Inc. (TSX:APH) have all struggled as of late, but there is no need to panic.
Here's why Canopy Growth Corp. (TSX:WEED) hasn't suffered the same magnitude of losses relative to its peers in the marijuana market.
Stocks like Aphria Inc. (TSX:APH) and MedReleaf Corp. (TSX:LEAF) have been pummeled as the cannabis market has corrected sharply since February.
Why the new IPO of The Green Organic Dutchman is likely to exhibit some aspects of recent M&A activity in the sector (i.e. Aphria Inc.'s (TSX:APH) Acquisition of Nuuvera Inc.)
A cold rain beat down recently on the boarded-up cinder-block homes and empty factories of Smiths Falls, Ontario, melting the last snows in this industrial town about an hour south of Ottawa. Inside a shuttered chocolate factory, it is artificial summer for the marijuana crop of the largest cannabis company in the world, Canopy Growth. In brightly lit, high-tech “grow rooms,” Canopy is preparing for the expected legalization of recreational cannabis this year in Canada—the first industrialized nation to do so at the federal level.